RE: Open Offer1 Jun 2022 10:17
"My view is ODX should be valued, compared to peer metrics, IRO £15m to £20m or 6.5p to 8.5p a share based on 238m issued shares right now BEFORE any further developments/upside in the Health & Nutrition business, not forgetting the possibility of a takeover approach."
so you are valuing a company that after 30 years still can't turn enough profit to survive without a placing - at £20m.
uuummm..good luck with that. the market values it at £7m ish
the "possibility" of a takeover - no indication of any such thing . lets see if they can sell CD4 first.
the sold alva at a huge loss